Hunan Province Drug Inspectors, In Central China, Crack Down On Fake And Substandard Medicines, Devices
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Drug regulators in the central Chinese province of Hunan have taken action against more than 300 unlicensed pharmaceutical and medical device manufacturers during a "One Hundred Day Rectification Campaign" that concluded in August
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)